These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 8225532)

  • 1. Natriuretic and hypotensive effect of adenosine-1 blockade in essential hypertension.
    van Buren M; Bijlsma JA; Boer P; van Rijn HJ; Koomans HA
    Hypertension; 1993 Nov; 22(5):728-34. PubMed ID: 8225532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Natriuretic effect and changes in renal haemodynamics induced by enalapril in essential hypertension.
    Sánchez RA; Marcó E; Gilbert HB; Raffaele P; Brito M; Giménez M; Moledo LI
    Drugs; 1985; 30 Suppl 1():49-58. PubMed ID: 2994987
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Functional role of endogenous adenosine in human chronic renal disease.
    Balakrishnan VS; Coles GA; Williams JD
    Exp Nephrol; 1996; 4(1):26-36. PubMed ID: 8788597
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Four-hour infusions of synthetic atrial natriuretic peptide in normal volunteers.
    Biollaz J; Nussberger J; Porchet M; Brunner-Ferber F; Otterbein ES; Gomez H; Waeber B; Brunner HR
    Hypertension; 1986 Jun; 8(6 Pt 2):II96-105. PubMed ID: 2941372
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Repetitive natriuresis and blood pressure. Long-term calcium entry blockade with isradipine.
    Krusell LR; Jespersen LT; Schmitz A; Thomsen K; Pedersen OL
    Hypertension; 1987 Dec; 10(6):577-81. PubMed ID: 2447016
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of inhibition of converting enzyme on renal hemodynamics and sodium management in polycystic kidney disease.
    Torres VE; Wilson DM; Burnett JC; Johnson CM; Offord KP
    Mayo Clin Proc; 1991 Oct; 66(10):1010-7. PubMed ID: 1921483
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Renal hemodynamics and sodium excretion after acute and chronic administration of cicletanine in normotensive and hypertensive subjects.
    Moulin B; Fillastre JP; Godin M; Coquerel A; Decoopman E
    J Cardiovasc Pharmacol; 1995 Feb; 25(2):292-9. PubMed ID: 7752655
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs.
    Maack T; Marion DN; Camargo MJ; Kleinert HD; Laragh JH; Vaughan ED; Atlas SA
    Am J Med; 1984 Dec; 77(6):1069-75. PubMed ID: 6239544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Enhanced sodium retention after acute nitric oxide blockade in mildly sodium loaded patients with essential hypertension.
    Bech JN; Nielsen EH; Pedersen RS; Svendsen KB; Pedersen EB
    Am J Hypertens; 2007 Mar; 20(3):287-95. PubMed ID: 17324742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Renal effects of local infusion of adenosine in man.
    Edlund A; Ohlsén H; Sollevi A
    Clin Sci (Lond); 1994 Aug; 87(2):143-9. PubMed ID: 7924159
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cardiovascular and renal effects of blocking A1 adenosine receptors.
    Kuan CJ; Herzer WA; Jackson EK
    J Cardiovasc Pharmacol; 1993 May; 21(5):822-8. PubMed ID: 7685455
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Renal mechanisms of human alpha-atrial natriuretic peptide in man.
    Brown J; Corr L
    J Physiol; 1987 Jun; 387():31-46. PubMed ID: 2958623
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal renal responses to calcium entry blockade in normotensive offspring of hypertensive parents.
    Montanari A; Vallisa D; Ragni G; Guerra A; Colla R; Novarini A; Coruzzi P
    Hypertension; 1988 Nov; 12(5):498-505. PubMed ID: 2847983
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of sodium retention in heart failure: relation to the renin-angiotensin-aldosterone system.
    Eiskjaer H; Bagger JP; Danielsen H; Jensen JD; Jespersen B; Thomsen K; Sørensen SS; Pedersen EB
    Am J Physiol; 1991 Jun; 260(6 Pt 2):F883-9. PubMed ID: 1647690
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal and hormonal effects and tolerance of an ANP analogue in healthy man.
    Eiskjaer H; Schmiegelow M; Jespersen B; Tietze IN; Jensen JD; Sørensen SS; Thomsen K; Pedersen EB
    Eur J Clin Pharmacol; 1991; 41(6):547-54. PubMed ID: 1840038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Natriuretic and renal hemodynamic effects of nicardipine in essential hypertension.
    Chaignon M; Bellet M; Lucsko M; Rapoud C; Guédon J
    Kidney Int Suppl; 1988 Sep; 25():S184-6. PubMed ID: 3054236
    [No Abstract]   [Full Text] [Related]  

  • 17. Caffeine attenuates the renal vascular response to angiotensin II infusion.
    Brown NJ; Ryder D; Nadeau J
    Hypertension; 1993 Dec; 22(6):847-52. PubMed ID: 8244516
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Atrial natriuretic factor influences renal diurnal rhythm in essential hypertension.
    Janssen WM; de Zeeuw D; van der Hem GK; de Jong PE
    Hypertension; 1992 Jul; 20(1):80-4. PubMed ID: 1535613
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pressure-dependent distal tubular action of atrial natriuretic peptide in healthy humans.
    Eiskjaer H; Nielsen CB; Pedersen EB
    J Hypertens; 1996 Jan; 14(1):99-106. PubMed ID: 12013501
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effects of interrupting the renin-angiotensin system on sodium excretion in man.
    Brown J
    J Physiol; 1988 Jan; 395():17-40. PubMed ID: 3045295
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.